MitoQ Mitoquinol
Commercial- Indications
- Heart health, Cellular aging, Oxidative stress
Company intelligence / Profile preview
MitoQ’s patented mitochondria-targeted antioxidant molecule has been extensively researched in over two dozen clinical trials demonstrating benefits such as reduced cell stress, improved energy metabolism, enhanced exercise recovery, immune support, cardiovascular benefits especially in older populations including post-menopausal women. The effects build over time with consistent use.[1][3][5]
Independent studies exceed $60 million investment with more than 750 peer-reviewed papers supporting safety and efficacy.[1][3][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MitoQ.